Specifically, PICK1 upregulation in prostate cancer cells inhibited nuclear translocation of pSMAD2/3 and suppressed the expression of TGF-β target genes both in the presence and absence of TGF-β. The gene discussed is TGFB1; the disease is prostate carcinoma.